Abstract:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) XBB lineages have achieved dominance worldwide and keep on evolving. Convergent evolution of XBB lineages on the receptor-binding domain (RBD) L455F and F456L is observed, resulting in variants with substantial growth advantages, such as EG.5, FL.1.5.1, XBB.1.5.70, and HK.3. Here, we show that neutralizing antibody (NAb) evasion drives the convergent evolution of F456L, while the epistatic shift caused by F456L enables the subsequent convergence of L455F through ACE2 binding enhancement and further immune evasion. L455F and F456L evade RBD-targeting Class 1 public NAbs, reducing the neutralization efficacy of XBB breakthrough infection (BTI) and reinfection convalescent plasma. Importantly, L455F single substitution significantly dampens receptor binding; however, the combination of L455F and F456L forms an adjacent residue flipping, which leads to enhanced NAbs resistance and ACE2 binding affinity. The perturbed receptor-binding mode leads to the exceptional ACE2 binding and NAb evasion, as revealed by structural analyses. Our results indicate the evolution flexibility contributed by epistasis cannot be underestimated, and the evolution potential of SARS-CoV-2 RBD remains high. The continuous evolution of SARS-CoV-2 presents a challenge to global public health and the development of vaccines and treatments against COVID-19. Recently, an adjacent residue alteration, L455F+F456L, also known as "FLip", on the receptor-binding domain of the virus, which has been identified in multiple strains of the virus, alters how the virus interacts with human cells and immune response. We show that the combination of these mutations synergistically increases the virus's ability to bind to ACE2, the primary receptor on cell surfaces, enabling it to specifically escape a public type of neutralizing antibodies elicited by vaccination and infection, and the molecular mechanisms are explained by structural analyses. The enhancement of receptor binding increases the potential of the virus to further accumulate immune evasive mutations. These findings broaden our understanding of SARS-CoV-2 evolution and highlight the importance of paying attention to these ongoing antigenic drifts in the virus as we continue to develop and evaluate current antibody therapeutics and vaccines.

Altered receptor binding, antibody evasion and retention of T cell recognition by the SARS-CoV-2 XBB.1.5 spike protein

ACE2 Binding and Antibody Evasion in Enhanced Transmissibility of XBB.1.5

SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition

Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike

Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion

Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455–456 synergistically enhances antibody evasion and ACE2 binding

The XBB.1.5 slightly increase the binding affinity for host receptor ACE2 and exhibit strongest immune escaping features: molecular modeling and free energy calculation

Spike structures, receptor binding, and immune escape of recently circulating SARS-CoV-2 Omicron BA.2.86, JN.1, EG.5, EG.5.1, and HV.1 sub-variants

Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement

Antigenicity and infectivity characterization of SARS-CoV-2 BA.2.86

Immune Evasion, Cell-Cell Fusion, and Spike Stability of the SARS-CoV-2 XEC Variant: Role of Glycosylation Mutations at the N-terminal Domain

Structural Basis for Continued Antibody Evasion by the SARS-CoV-2 Receptor Binding Domain

Structural insights into immune escape at killer T cell epitope by SARS-CoV-2 Spike Y453F variants

High-throughput screening of spike variants uncovers the key residues that alter the affinity and antigenicity of SARS-CoV-2

Cooperation of Binding Hotspots in Mediating Epistatic Couplings Underlies Binding Mechanism and Immune Escape

Altered spike dynamics drives immune evasion of SARS-CoV-2

Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion

A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2

Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant

Molecular Insights into the Variability in Infection and Immune Evasion Capabilities of SARS-CoV-2 Variants: A Sequence and Structural Investigation of the RBD Domain